Skip to main content
. Author manuscript; available in PMC: 2021 Aug 4.
Published in final edited form as: Urology. 2017 Aug 25;110:76–83. doi: 10.1016/j.urology.2017.08.024

Table 1.

Baseline characteristics of the SEER-Medicare cohort

Radical Cystectomy
Characteristics Total No Col. %* Yes Col. %* P Value
Year of diagnosis <.001
 2006 942 689 17.5 253 18.4
 2007 905 651 16.5 254 18.4
 2008 908 655 16.6 253 18.4
 2009 848 622 15.8 226 16.4
 2010 866 631 16.0 235 17.1
 2011 856 700 17.7 156 11.3
Age group <.001
 66–69 748 454 11.5 294 21.4
 70–74 1029 650 16.5 379 27.5
 75–79 1217 852 21.6 365 26.5
 80+ 2331 1992 50.5 339 24.6
Sex <.001
 Male 3612 2758 69.9 854 62.0
 Female 1713 1190 30.1 523 38.0
Race .01
 Non-Hispanic white 4605 3425 86.8 1180 85.7
 Non-Hispanic black 306 240 6.1 66 4.8
 Hispanic 170 114 2.9 56 4.1
 Other 244 169 4.3 75 5.4
Marital status <.001
 Single 843 628 15.9 215 15.6
 Married 2875 2049 51.9 826 60.0
 Unknown 1607 1271 32.2 336 24.4
Median household income, $ <.01
 <$45,470 1412 1086 27.5 326 23.7
 $45,470–$54,375 1305 986 25.0 319 23.2
 $54,376–$63,511 1304 943 23.9 361 26.2
 ≥$63,511 1304 933 23.6 371 26.9
Stage <.001
 II 3036 2461 62.3 575 41.8
 III 881 468 11.9 413 30.0
 IV 1408 1019 25.8 389 28.2
Hydronephrosis .02
 No 4704 3464 87.7 1240 90.1
 Yes 621 484 12.3 137 9.9
Grade <.001
 Low 253 207 5.2 46 3.3
 High 4738 3440 87.1 1298 94.3
 Unknown 334 301 7.6 33 2.4
Comorbidity score <.001
 0 2736 1938 49.1 798 58.0
 1 1359 985 24.9 374 27.2
 2 613 494 12.5 119 8.6
 3+ 617 531 13.4 86 6.2
Lymph node dissection
 No 150 - - 150 10.9
 Yes 1227 - - 1227 89.1
Neoadjuvant chemotherapy
 No 1148 - - 1148 83.4
 Yes 229 - - 229 16.6
*

Percentages reported in each row is column percentage calculated by dividing the number of patients in each row by the total number of patients in that column.

P values derived using chi-square test.